EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

YiQi GuBen formula alleviates airway inflammation and airway remodeling in OVA-induced asthma mice through TLR4/NF-κB signaling pathway

Yibu Kong, Zhongtian Wang, Hongjun Yu, Aiai Dong, Yongfu Song, Lei Guo, Jinpu Zhu, Liping Sun, Yinan Guo iD

Journal of Pharmacy and Pharmacology · 2024

DOI: 10.1093/jpp/rgae064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Yibu Kong und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medical, No.1035, Boshuo Road, Jingyue District, Changchun 130017, China. Hauptthemen laut MEDLINE: Asthma, Toll-Like Receptor 4, Airway Remodeling, Ovalbumin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Development Plan Project of Jilin Provincial, 2023 Youth Excellent Discipline Backbone Training Project of Changchun University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aim to investigate the effect of YiQi GuBen formula (YQGB) on airway inflammation and airway remodeling in the ovalbumin (OVA)-induced asthma model to further explore the potential mechanisms of YQGB in treating allergic asthma.

Methods

Mice were divided into five groups randomly (n = 10): the control group, OVA group, OVA + Dex (0.1 mg/kg) group, OVA + low-dose (1.1 g/kg) YQGB group, and OVA + high-dose (2.2 g/kg) YQGB group. Inflammatory cell count and IgE were detected in bronchoalveolar lavage fluid (BALF). Lung tissue histopathology was observed by using H&E, PAS, Masson, and immunohistochemistry staining. qRT-PCR and western blot were applied to analyze key genes and proteins associated with TLR4 and NF-κB signaling pathways.

Results

In OVA-induced asthma mice, YQGB decreased eosinophils and IgE in BALF. YQGB alleviated the OVA-induced inflammatory infiltration and declined IL-4, IL-5, IL-13, Eotaxin, ECP, GM-CSF, LTC4, and LTD4. YQGB attenuated the OVA-induced goblet cell metaplasia and mucus hypersecretion. YQGB mitigated the OVA-induced subepithelial fibrosis and lowered TGF-β1, E-Cadherin, Vimentin, and Fibronectin. YQGB ameliorated the OVA-induced airway smooth muscle thickening and lessened α-SMA and PDGF levels. YQGB reduced the expression of TLR4, MyD88, TRAF6, IκBα, and p65 mRNAs, and IκBα and p-p65 protein levels were also reduced.

Conclusion

YQGB exhibits the anti-asthma effect by reducing airway inflammation and airway remodeling through suppressing TLR4/NF-κB signaling pathway, and is worth promoting clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaToll-Like Receptor 4Airway RemodelingOvalbuminSignal TransductionNF-kappa BDrugs, Chinese HerbalMice, Inbred BALB CBronchoalveolar Lavage FluidDisease Models, AnimalAnimalsMiceImmunoglobulin ELungFemaleInflammationEosinophilsAnti-Asthmatic AgentsCytokines

Stichwörter der Autor:innen

YiQi GuBen formulaairway inflammationairway remodelingallergic asthma

Substanzen

Toll-Like Receptor 4OvalbuminNF-kappa BDrugs, Chinese HerbalTlr4 protein, mouseImmunoglobulin EAnti-Asthmatic AgentsCytokines

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Changchun University of Chinese Medical, No.1035, Boshuo Road, Jingyue District, Changchun 130017, China.
  • Department of Pediatrics, The Affiliated Hospital to Changchun University of Chinese Medicine, No. 1478, Gongnong Road, Chaoyang District, Changchun 130021, Jilin, China.

ORCID-Profile: Yinan Guo

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Development Plan Project of Jilin Provincial
  • 2023 Youth Excellent Discipline Backbone Training Project of Changchun University of Traditional Chinese Medicine
  • Scientific Research Project of Jilin Provincial Department of Education

Zitieren

APA

Kong, Y., Wang, Z., Yu, H., Dong, A., Song, Y., Guo, L., Zhu, J., Sun, L., & Guo, Y. (2024). YiQi GuBen formula alleviates airway inflammation and airway remodeling in OVA-induced asthma mice through TLR4/NF-κB signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae064

Vancouver

Kong Y, Wang Z, Yu H, Dong A, Song Y, Guo L, et al. YiQi GuBen formula alleviates airway inflammation and airway remodeling in OVA-induced asthma mice through TLR4/NF-κB signaling pathway. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae064

BibTeX
@article{Kong2024,
  author = {Kong, Yibu and Wang, Zhongtian and Yu, Hongjun and Dong, Aiai and Song, Yongfu and Guo, Lei and Zhu, Jinpu and Sun, Liping and Guo, Yinan},
  title = {YiQi GuBen formula alleviates airway inflammation and airway remodeling in OVA-induced asthma mice through TLR4/NF-κB signaling pathway},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  doi = {10.1093/jpp/rgae064}
}
Kostenlos starten →